GRACEcast
ASCO Lung Cancer Highlights, Part 12: Ganetespib with Second Line Chemotherapy for Advanced NSCLC (audio)
- Autor: Podcast
- Narrador: Podcast
- Editora: Podcast
- Duração: 0:05:41
- Mais informações
Informações:
Sinopse
Dr. Edward Garon, David Geffen School of Medicine at UCLA, reviews impressive results from the GALAXY-1 trial of the heat shock protein inhibitor ganetespib combined with combined with second line docetaxel in advanced lung adenocarcinoma.
